Company Description
Baseball players and AVANIR Pharmaceuticals know: A sacrifice is sometimes the only way to get ahead. The drug development firm in 2007 opted to...
Key AVANIR Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): AVNR Main Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2007 Sales (mil.) | $9.2 |
| 2005 Employees | 76 |
More AVANIR Pharmaceuticals Financials (10 pages)
Latest AVANIR Pharmaceuticals Jobs powered by Monster.com
- Clinical Research Associate (Contract)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about AVANIR Pharmaceuticals's competition across multiple industries
Top AVANIR Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryAVANIR Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Keith A. Katkin | Network | E-mail |
| VP, Sales | Matthew R. (Matt) Ruth | Network | E-mail |
| VP Communications | Eric Benevich | Network | E-mail |
More AVANIR Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current AVANIR Pharmaceuticals News
- Avanir Pharmaceuticals (AVNR) Corporate Event Announcement Notice [Wall Street Horizon] (14 May 2008 20:40:00 EDT)
- Avanir Pharmaceuticals (AVNR) Corporate Event Announcement Notice [Wall Street Horizon] (13 May 2008 20:42:00 EDT)
- AVNR: Q2 Earnings Call @ 11:00 ET Today [delayed] [Knobias.com] (13 May 2008 08:25:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.





